Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
QS127: Obesity in adults: quality standard
Mod GRF 1-29 is available in 2 mg and 5 mg dosages, providing more flexibility for users
Not everyone is a candidate or responder, and many discontinue therapy early data from Prime Therapeutics shows only 1 in 12 members remain on treatment after three years
The FDA has signaled intent to take enforcement action against certain mass-marketed non-FDA-approved GLP-1 products and has drawn a clear distinction between mass-marketed compounded products and patient-specific compounding that may remain permissible in narrow circumstances
US$ 29.12
US$ 28.22
US$ 24.36
US$ 26.12
US$ 21.17
US$ 29.20
